论文部分内容阅读
洛伐他汀是第一个用于临床的他汀类调整血脂药物,INN命名为Lovastatin,它首先由美国默克公司开发成功,并于1987年上市。它的上市被誉为降血脂药物研究进展的一个里程碑。原国家医药管理局四川抗菌素工业研究所从
Lovastatin is the first statin-modifying lipid-lowering drug for clinical use. INN is named as Lovastatin. It was first developed by Merck in the United States and was launched in 1987. Its listing is hailed as a milestone in the progress of lipid-lowering drugs. The former State Pharmaceutical Administration Sichuan Institute of antibiotics from